Category: Clinical Trials
Medical science policy in the U.S. under Donald Trump eighty days in
A week after Donald Trump was elected, I speculated about how he would affect medical science policy. Now, 80 days into the Trump administration, we have some observations.
Corrigendum. The Week in Review for 04/09/2017
The NECSS is coming. Acupuncturists mimic chiropractic. Flu vaccine prevents death. In the UK they care more for cats than people. The problem is my middle burner, not too many burgers. And more.
Treating Chronic Fatigue Syndrome with Cognitive Behavioral Therapy and Graded Exercise Therapy: How the PACE Trial Got It Wrong
The PACE trial found that cognitive behavioral therapy and graded exercise therapy were effective treatments for chronic fatigue syndrome and could produce recovery in 22% of patients. It seems they got it wrong.
Corrigendum. The Week in Review for 04/02/2017
Death from vaccine-preventable infections. Homeopathy and acupuncture do not work. There is a difference between cost and worth. And more.
Vitamin C and Sepsis. All Sound and Fury? Much Ado About Nothing?
Is intravenous vitamin C helpful in sepsis? I hope so, but past experience render me skeptical.
Stem Cells for Macular Degeneration: Meticulous Science vs. Unethical Carelessness
Rigorous scientists stabilized a patient’s macular degeneration with a cutting-edge stem cell treatment; less rigorous scientists misapplied stem cell science and left three women blind.
Update on Testosterone Supplementation
Testosterone supplementation is a legitimate treatment for properly-diagnosed androgen deficiency, but it is being overprescribed by doctors who make exaggerated claims for it. New evidence clarifies its modest benefits and worrisome risks.
The Texas Medical Board lets Stanislaw Burzynski off lightly: A cautionary tale of the failure of regulating medicine
After three years and countless twists and turns, the final decision by the Texas Medical Board on the sanctions to be imposed on Houston cancer quack Dr. Stanislaw Burzynski were announced on Friday. Sadly, they were not enough. The Burzynski saga should serve as a cautionary tale that the regulation of physicians and medicine is too lax, not too strict.

